Marie Fernandes
15
Documents
Publications
Publications
MET exon 14 skipping mutation is a HGF‐dependent oncogenic driver in vitro and in humanized HGF knock‐in miceMET in cancer, Nov 2023, Lille, France |
|
|
An Extracellular Matrix-like hydroscaffold for 3D cell culture to bring the gap between in vitro & in vivo: focus on cancer models2023 ELRIG Research & Innovation Conference, Mar 2023, Cambridge, United Kingdom. |
Improving therapeutic strategies for METex14-mutated lung cancersGoodbye flat biology : next generation cancer models, Oct 2023, Berlin, Germany |
|
Development of personalized therapeutic targeting in lung cancer with METex14 mutationONCOlille Days, Nov 2022, Lille, France |
|
|
|
Co-activation of the invasion and survival contributes to transformation induced by exon 14 splicing of MET receptor in lung cancer3rd International Symposium Research on Healthy Ageing, Dec 2019, Lille, France |
Abstract 3683: MET Exon 14 Skipping Mutations in Lung Cancer: Screening, Functional and Clinical ImpactAmerican Association for Cancer Research Annual Meeting 2020, Jun 2020, On line, United States. 80 (16_Supplement), pp.3683, 2020, ⟨10.1158/1538-7445.AM2020-3683⟩ |
|
|
Oncogenic mutations convert MET from a pro-apoptotic tumor suppressor to an oncogenic driver2025 |
|
|
Implication du saut de l’exon 14 du récepteur MET dans le cancer du poumon : caractérisation des mécanismes d’activationMédecine humaine et pathologie. Université de Lille, 2021. Français. ⟨NNT : 2021LILUS009⟩ |
Chargement...
Chargement...